In sum, these data suggest that IDO contributes to multiple aspects of NAFLD progression and that non-hematopoietic IDO activity may play a key role in regulating NAFLD pathogenesis. The gene discussed is IDO1; the disease is metabolic dysfunction-associated steatotic liver disease.